Advanced search

Find pages with...
Then narrow your results by...

About 19 search results

Dozens of health products seized from Aphrodite Aesthetic Clinic in North York, Ontario, may pose serious health risks

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/70749a-eng.php

Feb 6, 2020 ... liver injury, gallstones, kidney stones and kidney damage. It should not be used by patients with chronic malabsorption, gallbladder problems or by those who are allergic to orlistat. It should be used with caution in patients taking cyclosporine, diabetic or thyroid medication, and those with bowel disease or kidney damage. Because it affects absorption from

Multiple unauthorized eye solutions and an acne gel sold at two stores in the Lower Mainland of BC may pose serious health risks

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/69608a-eng.php

Apr 15, 2019 ... weakness and skin rash. Clindamycin in topical format is a prescription antibiotic approved in Canada to treat bacterial infections, including those associated with acne. The product should not be used in individuals with a history of ulcerative colitis (inflamed bowel) or a history of inflamed bowel associated with antibiotic use (antibiotic-associated colitis

Important safety information on Fleet Phospho-Soda (sodium phosphates oral solution) with kidney impairment and nephrocalcinosis - For Health Professionals - MERCK Consumer Pharmaceuticals

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2005/14361a-eng.php

Feb 6, 2013 ... Canada, would like to inform you of important new safety information for Fleet® Phospho-Soda® (Sodium Phosphates Oral Solution). Sodium phosphates oral solution is commonly used as a purgative for bowel cleansing prior to patients going to surgery or for preparing the colon for x-ray or endoscopic examination. Appropriate patient screening and adequate hydration

Important safety information on pms-Sodium Phosphates Oral Solution with kidney impairment and nephrocalcinosis - For Health Professionals - Pharmascience Inc.

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2005/14360a-eng.php

Feb 6, 2013 ... of phosphorus) in a 24-hour period is exceeded. Three papers, involving seven case reports, have been published reporting nephrocalcinosis associated with renal failure following administration of Fleet™ Phospho-Soda®, or other oral sodium phosphate preparations, when used as a bowel cleanserFootnote 1 Footnote 2 Footnote 3. In some cases acute renal failure

Hospital Beds - Risk of Patient Entrapment

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2017/62960a-eng.php

Aug 10, 2018 ... and bladder and/or bowel dysfunctions. Although limited information is available about the circumstances and factors leading to the specific cases of patient entrapment, all reported cases of death indicated the involvement of the bed rails in the entrapment. Consequently, the risk associated with the use of bed rails should be evaluated, taking into consideration

Herbal detox and laxative products Formule L1 and Detox Spring Fall recalled due to missing risk statements on label

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/38149a-eng.php

Feb 27, 2014 ... practitioner prior to use if you have a kidney disorder or are taking prescription medication (e.g. cardiac glycosides or antiarrhythmic medications); if you have faecal impaction or symptoms such as abdominal pain, nausea, vomiting or fever; if you have gallstones. Reduce dose or discontinue use if you experience abdominal pain, cramps, spasms, and/or diarrhea

RELISTOR (Methylnaltrexone Bromide) Subcutaneous Injection – Association with Gastrointestinal Perforation – For the Public

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2010/14087a-eng.php

Mar 7, 2013 ... with advanced illness who are receiving palliative care. When response to laxatives has been insufficient, RELISTOR should be used as an add-on therapy to induce a prompt bowel movement. If you have advanced illness and are being treated with RELISTOR, you may be at increased risk of gastrointestinal perforation especially in the presence of conditions that weaken

Sutent (sunitinib malate) - Cases of Severe Skin Reactions - For the Public

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2013/35475a-eng.php

Sep 6, 2013 ... (sunitinib malate) with cases of severe skin reactions Pfizer Canada Inc. (manufacturer of Sutent), in collaboration with Health Canada, would like to inform you about an important revision to the Product Monograph, including the consumer information section, for Sutent (sunitinib malate). Sutent is a medication that is used to treat cancer of the stomach and bowels

RELISTOR (methylnaltrexone bromide) Subcutaneous Injection - Association with Gastrointestinal Perforation - For Health Professionals

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2010/14622a-eng.php

... is indicated for the treatment of opioid-induced constipation in patients with advanced illness who are receiving palliative care. When response to laxatives has been insufficient, RELISTOR is used as an adjunct therapy to induce a prompt bowel movement. Patients with advanced illness being treated with RELISTOR may be at increased risk of GI perforation if they have

Search results

https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/search-recherche/simple?js_en=&page=1000&per_page=19000&plain_text=&s=

Mar 30, 2012 .... Consumers may continue to use the DVD/CD/MP3 players with AC or DC power adapters until they receive the replacement battery. For more information, consumers... Posted: 2009-12-09 Type of communication: Recall Important Information About Acai Berry Products Containing Prescription Medication (Updated January 15, 2010) Important Information About Acai Berry Products

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: